BioHarvest to Showcase Growth Strategy at March Roth Conference Post-Q4 Financing
BioHarvest Sciences will host one-on-one meetings at the 38th Annual Roth Conference on March 22-24, 2026 to showcase its growth strategy after a Q4 2025 financing round that fully funded near-term CapEx. The company serves over 85,000 direct customers and holds anchor CDMO research partnerships to fuel 2026 growth.
1. Roth Conference Participation
BioHarvest Sciences management, led by CEO Ilan Sobel, will meet one-on-one with institutional investors at the 38th Annual Roth Conference, scheduled for March 22-24, 2026 at The Ritz-Carlton Laguna Niguel in Dana Point, CA.
2. Strong Financial Backing
The company closed a successful Q4 2025 financing round that fully funded its near-term capital expenditure requirements, enabling focus on commercial expansion without immediate fundraising needs.
3. Growth Strategy and Partnerships
BioHarvest leverages its patented Botanical Synthesis platform across CDMO services and consumer products, serving over 85,000 direct customers and partnering on anchor research collaborations to drive significant growth milestones in 2026.